Sulfisozole is a sulfonamide antibiotic belonging to the dihydropteroate synthase inhibitor class, primarily utilized for treating urinary tract infections and various other bacterial conditions. Laboratories… Read more
Sulfisozole is a sulfonamide antibiotic belonging to the dihydropteroate synthase inhibitor class, primarily utilized for treating urinary tract infections and various other bacterial conditions. Laboratories require access to high-quality related compounds to ensure rigorous analytical testing and quality control of the active pharmaceutical ingredient. This category features critical reference standards, including identified impurities and metabolites, alongside stable isotope labelled compounds essential for precise quantification. These materials are fundamental for impurity profiling and method validation throughout the drug development lifecycle. By utilizing these chemically characterized substances, researchers can accurately monitor stability, assess pharmacokinetic profiles, and ensure compliance with regulatory standards for pharmaceutical purity and efficacy in clinical applications.